The Food and Drug Administration today authorized for emergency use the first prescription antibody test that allows individuals to collect a finger-stick dried blood sample at home for analysis at a Symbiotica laboratory when a health care provider deems it appropriate.

The COVID-19 Self-Collected Antibody Test System can help identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. 

Related News Articles

Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…